FreeGuest Editorial First exhibit at Museum of Medicine and Biomedical Discovery to focus on the history of cancer researchFrom despair to discovery to triumph May 16, 2025Vol.51 No.19By Mace L. Rothenberg
Sponsored City of Hope research showcases innovation at 2025 AACR annual meeting May 16, 2025Vol.51 No.19By City of Hope
FreeIn the Archives Ashtrays in ivory towers: Two centuries of tobacco’s ties to academia May 16, 2025Vol.51 No.19
Trump administration is removing the mainstays of NCI and the federal government’s cancer programPeer review, registries, and evidence-based patient information take a big hit May 09, 2025Vol.51 No.18By Paul Goldberg and Jacquelyn Cobb
Guest Editorial George Weiner: Cancer centers are special, as are site visits in CCSG review May 09, 2025Vol.51 No.18By George J. Weiner
Regulatory News Cyber-iconoclast Vinay Prasad named head of FDA’s CBERAn oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies May 09, 2025Vol.51 No.18By Claire Marie Porter
FreeTrials & Tribulations Working with cancer: Rethinking long-term health for working-age adult cancer survivors May 09, 2025Vol.51 No.18By Susan A. Speckhart, Rebecca Miksad and Lidia Schapira
Sponsored Rewriting the rules of cancer treatment one nanobody at a time May 09, 2025Vol.51 No.18By John D. Fryer
FreeIn the Archives Walter Lawrence Jr.: “The National Cancer Act really gave us a lot of enthusiasm about the future.” May 09, 2025Vol.51 No.18By Katie Goldberg
Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors May 02, 2025Vol.51 No.17By Jacquelyn Cobb
